Video Experimental Relacionado
Updated: Jul 13, 2026
05:51
Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Desarrollo de vacunas contra la enfermedad meningocócica
Luis Jódar1, Ian M Feavers, David Salisbury
1Vaccine Development and Quality and Safety of Biologicals, World Health Organization, Geneva, Switzerland. jodar@who.org
Lancet (London, England)
|May 4, 2002
Resumen
El desarrollo de nuevas vacunas contra Neisseria meningitidis grupo B es un desafío. Los datos genómicos revelan proteínas de membrana conservadas prometedoras que pueden ofrecer una amplia protección contra la enfermedad meningocócica.
Área de la Ciencia:
- Microbiología Microbiología.
- Vacunología La vacunología.
- La genómica es la genómica.
Sus antecedentes:
- La Neisseria meningitidis es la causa de la meningitis bacteriana y la sepsis.
- Las vacunas existentes se dirigen a serogrupos específicos, pero el grupo B sigue siendo un desafío.
- Las vacunas convencionales para el grupo B han fracasado en gran medida debido a la diversidad de antígenos y la inducción de autoanticuerpos.
Objetivo del estudio:
- Para explorar nuevos candidatos a vacunas para Neisseria meningitidis grupo B.
- Para identificar antígenos conservados para la protección de amplio espectro.
- Para superar las limitaciones de las estrategias actuales de desarrollo de vacunas.
Principales métodos:
- Análisis de secuenciación genómica para identificar nuevos antígenos.
- Evaluación de nuevas proteínas de membrana como candidatos a vacunas.
- Evaluación de la respuesta inmune, incluidos los anticuerpos bactericidas séricos en modelos murinos.
Principales resultados:
- Los análisis genómicos identificaron numerosas nuevas proteínas de membrana.
- Estos antígenos conservados provocan anticuerpos bactericidas séricos en ratones.
- Los nuevos candidatos a vacunas son prometedores para una amplia protección contra las cepas del grupo B.
Conclusiones:
- Las proteínas de membrana conservadas representan objetivos prometedores para una vacuna de Neisseria meningitidis grupo B de protección amplia.
- Los conocimientos genómicos son cruciales para desarrollar vacunas efectivas contra patógenos bacterianos difíciles.
- Existen mejores perspectivas para el control de todas las enfermedades meningocócicas a nivel mundial.
Videos de Conceptos Relacionados
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...